Delivery Order SPE2DB25D3018-SPE2DB25FUYNV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) valued at $9,087.02. The contract, awarded on September 24, 2025, with completion targeted for September 25, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award selection. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the performance location, and the company...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,397.80. This award, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, utilizes firm fixed price terms under a non-set-aside, competitively awarded contract. The place of performance is the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a task...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) with a contract value of $1,587.03. This non-set-aside, competitively awarded delivery order was executed on September 11, 2025, with an ultimate completion date of September 12, 2025, utilizing firm fixed-price terms. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $1,957.52 to AmerisourceBergen Drug Corp for Adderall XR 20 mg capsules (100 count) on August 12, 2025, with an ultimate completion date of August 13, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The product will be delivered to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,445.57 to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) under a firm fixed price contract type. The award was made on September 25, 2025, with an ultimate completion date of September 26, 2025, and represents a non-set-aside competitive award. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $6,249.17. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 24, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions...
- The Defense Logistics Agency awarded a delivery order valued at $1,515.34 to AmerisourceBergen Drug Corp for 100 capsules of Adderall XR 20 mg, with a completion date of September 26, 2025. This is a firm fixed price, non-set-aside contract with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,388.24 for 100 capsules of Adderall XR 30 mg on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen Drug Corp's larger contractual...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,885,146 units of Adderall XR 20 mg capsules. The contract has a potential value of $2,210.28 and a completion date of March 8, 2024. Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, is a for-profit organization that serves as a prime contractor providing pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 25 mg capsules (100-count units) with a ceiling value of $1,129.20. The contract, which was competitively awarded without set-aside designation, was finalized on March 11, 2025, with an ultimate completion date of March 12, 2025. The firm fixed price delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYNVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,187.40 to AmerisourceBergen Drug Corp for 100 capsules of Adderall XR 20 mg, with an ultimate completion date of September 18, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's established role as a major pharmaceutical distributor for federal medical systems, combined with its demonstrated capability to meet diverse pharmaceutical supply requirements across multiple therapeutic domains, positions the company as a critical vendor for DLA's medical supply chain serving the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/17/25 |